Transmucosal delivery platform · In development

Dissolve
the needle.

SteroNova is developing a thin, dissolvable strip that rests against the inside of the mouth and releases medicine gently across the mucosal barrier — no injection, no swallowing, nothing left behind on the skin.

Needle-free Discreet Controlled release Platform technology

Conceptual illustration · not to scale

01The problem

Every route into the body asks the patient to compromise.

Injections

Direct and effective — but invasive. For many people the needle itself becomes the reason a dose is delayed, dreaded, or skipped altogether.

Pills

Simple to take, but the digestive route is unforgiving. Many of the molecules that matter most are broken down long before they can reach where they are needed.

Topicals

Easy to apply, but they sit on the surface — where they can be rubbed off, absorbed unevenly, or transferred to the people around you.

The result is a whole category of therapy held back less by the medicine than by the way it has to travel. Better delivery is not a convenience feature. It is the difference between a treatment that exists and a treatment people actually stay on.

02The approach

A strip that meets the body where it is already open.

The tissue lining the inside of the mouth is thin, richly supplied with blood, and permeable by design. SteroNova is building a delivery strip made specifically for that surface — one that stays put, dissolves on its own schedule, and hands its payload across the barrier rather than pushing it through the gut.

Conceptual animation of a dissolvable strip releasing across the mucosal barrier A thin strip descends onto the lining of the mouth, adheres, dissolves gradually from one end to the other, and releases particles that cross the barrier into the bloodstream below. BLOODSTREAM MUCOSAL BARRIER STERONOVA STRIP
  1. 01

    Place

    The strip is set against the inside of the cheek. No water, no swallowing, no device.

  2. 02

    Adhere

    One face holds against the tissue and stays in place; the other keeps the payload where it belongs.

  3. 03

    Release

    The strip dissolves gradually rather than all at once — a steady handover instead of a single surge.

  4. 04

    Cross

    The payload passes through the mucosal barrier into circulation, taking a shorter path than the gut.

Conceptual illustration · not to scale · does not depict actual product design

03Why it matters

Small object. Large consequence.

A1

Needle-free by design

Nothing to pierce, nothing to dispose of. The barrier between a person and their treatment gets a great deal thinner.

A2

Nothing left on the skin

The strip goes where it is placed and stays there. There is no residue to rub off onto a partner, a child, or a pet.

A3

A steadier handover

Designed to release over time rather than in one burst — the goal is a smooth curve, not a peak followed by a valley.

A4

Discreet and portable

Flat, light, and quiet to use. It fits in a wallet, travels without ceremony, and asks nothing of the room you're in.

A5

Built for adherence

The easiest dose to take is the one people will actually take. Making delivery unremarkable is the point.

A6

A platform, not a product

One architecture, many molecules. What works for one therapeutic class is meant to carry over to the next.

Where we're pointing it

We are starting where the need is loudest and the delivery experience is the biggest obstacle, then extending the same platform outward.

  • Hormone therapyTherapies where today's options force a choice between invasive, inconsistent, or transferable.
  • PeptidesA class of medicine growing quickly, still largely tethered to the syringe.
  • And onwardThe platform is intentionally modular, so new molecules are an adaptation rather than a restart.

Contact

Get in touch.

Investors, clinicians, partners — or anyone thinking about the same problem.

inquiries@steronova.com